HDAC2 and cancer: Homozygous inactivation of HDAC2 occurs in sporadic CRC with MSI and hereditary nonpolyposis colon cancer syndrome, suggesting that these tumors may develop in the absence of HDAC2, a hypothesis that could have major implications for cancer therapy [16].